Summary:

Prof. Anna Pannaccione has been an Associate Professor in Pharmacology since 2019, specializing in neurodegeneration research, particularly in Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Her work focuses on the dysregulation of ionic homeostasis, especially ion channels and exchangers, employing electrophysiological techniques. With 68 peer-reviewed publications and three patents, she is actively engaged in multidisciplinary research collaborations both nationally and internationally.

Professional Experience

Prof. Pannaccione’s academic career is dedicated to discovering innovative therapies for neurodegenerative diseases like AD and PD. Her research emphasizes modulating Kv3.4 function, with the goal of developing therapeutic strategies to address energy failure and firing instability in neurodegenerative conditions.

Research Interests

Her research encompasses life sciences, focusing on neurological and neurodegenerative disorders, and the repair and regeneration of the nervous system. She is also a member of various research commissions, including SINS, SIF, and SfN, and serves as a referee for numerous international peer-reviewed journals.

Prof. Dal-Hee Min, Biomedical, Best Researcher Award

Dal-Hee Min at Seoul National University, South Korea

Profiles

Scopus

Orcid

Google Scholar

Academic Career and Research Focus

Dal-Hee Min, currently a distinguished Professor at Seoul National University and co-founder of Lemonex Inc., has forged an illustrious path in the realms of mRNA vaccines, gene therapy, and nanobiotechnology. With a solid foundation laid during her doctoral studies at the University of Chicago and subsequent postdoctoral research at MIT, she embarked on an academic journey that began at KAIST as an Assistant Professor in 2007. Transitioning to Seoul National University in 2011 marked a pivotal move in her career trajectory.

Awards and Recognition

Dal-Hee Min’s contributions have been celebrated with numerous accolades, including the prestigious KCS-Wiley Young Chemist Award, the Korea L’Oreal UNESCO Fellowship Award for Women in Science, and the esteemed Order of Science and Technology Merit (Do-Yak Medal) from the Korean Government. These recognitions underscore her significant impact and leadership in the field of nanomedicine and drug delivery systems.

Global Engagement and Leadership

Actively engaged in global scientific discourse, Dal-Hee Min has been a featured speaker at prominent venues such as the World Economic Forum, where she highlighted cutting-edge DDS technology. Her impactful presentations at international conferences like PODD, JP Morgan, and BIO USA underscore her role as a thought leader in advancing biotechnological frontiers.

Education and Professional Development

Dal-Hee Min’s academic journey is anchored by a robust educational background, including a Ph.D. in Chemistry from the University of Chicago and a master’s degree from Seoul National University. Her formative years at MIT as a postdoctoral researcher solidified her expertise in bioengineering, laying the groundwork for her pioneering research in nanomaterials and biomedical applications.

Innovative Research and Collaborations

At the forefront of her research endeavors are groundbreaking studies in drug delivery systems, leveraging nano-surface chemistry for applications ranging from mRNA vaccines to gene therapies. Her collaborative efforts have yielded impactful publications in top-tier journals, underscoring her commitment to advancing therapeutic modalities through innovative nanotechnological solutions.

📖 Publications:

Bio-inspired interfacial chemistry for the fabrication of a robust and functional graphene oxide composite film

Authors: Kwon, Y.-B., Cho, S., Min, D.-H., Kim, Y.-K.
Journal: RSC Advances
Year: 2024

Enhanced Local Delivery of Engineered IL-2 mRNA by Porous Silica Nanoparticles to Promote Effective Antitumor Immunity

Authors: Shin, H., Kang, S., Won, C., Min, D.-H.
Journal: ACS Nano
Year: 2023

3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing

Authors: Ahn, J., Kim, D.-H., Koo, D.-J., Kim, Y., Jeon, N.L.
Journal: Acta Biomaterialia
Year: 2023

Rod-to-sphere elemental reconstruction of biocompatible Ag2Te-Ag4.53-Te3 nanoparticles for triple negative breast cancer photo-nano-therapy

Authors: Ahn, H., Kang, S., Kang, K., Min, D.-H., Jang, H.
Journal: Journal of Materials Chemistry B
Year: 2023

Highly Efficient Messenger RNA Transfection of Hard-to-Transfect Cells using Carbon Nanodots

Authors: Shin, H., Min, D.-H.
Journal: Shin, H., Min, D.-H.
Year: 2023

Prof. Anna Pannaccione | Biomedical | Best Researcher Award

Prof. Anna Pannaccione | Biomedical | Best Researcher Award

Professor at Federico II University of Naples, Italy

Profiles

Summary:

Education

Professional Experience

Research Interests

Ultrafine particulate matter pollution and dysfunction of endoplasmic reticulum Ca2+ store: A pathomechanism shared with amyotrophic lateral sclerosis motor neurons?

Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation

Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators

The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity

Na+/Ca2+ exchanger isoform 1 takes part to the Ca2+-related prosurvival pathway of SOD1 in primary motor neurons exposed to beta-methylamino-l-alanine